Nav: Home

Texas Biomed scientist receives 5-year, $4.6 million MERIT Award for malaria research

January 25, 2017

San Antonio, Texas (January 25, 2017) - The study of drug resistance in the malaria parasite received a big boost today as Dr. Timothy Anderson, Scientist in the Department of Genetics at Texas Biomedical Research Institute, received a five-year, $4.6 million MERIT Award from the National Institutes of Health. MERIT Awardees must be nominated by an NIH representative.

A very small number of these coveted awards are given each year to provide "long-term, stable support to investigators whose research competence and productivity are distinctly superior and who are likely to continue to perform in an outstanding manner," according to NIH background information.

"I am delighted to receive this award, and it is a testament to the excellent researchers who have worked in my laboratory over the past 17 years and to their efforts to understand the basic biological processes underlying drug resistance evolution in malaria parasites," said Dr. Anderson. "No good vaccines are available, so effective treatment of malaria patients is critical to malaria control efforts worldwide."

The NIH MERIT award will enable Dr. Anderson and his team to expand their efforts to examine resistance evolution in Southeast Asia and to apply powerful new gene editing technologies to better understand drug resistance evolution.

"Unfortunately, evolution of resistance to drug treatment complicates efforts to control malaria," Dr. Anderson said. "Our aim is to identify the parasite genes that underlie resistance, to determine how frequently resistance arises, to monitor the spread of resistance and then to use this information to help design treatment strategies that can prevent resistance from arising in the first place."

"This award is well-deserved due to Dr. Anderson's groundbreaking research on drug resistance. His work not only contributes to the multi-billion dollar bio-science industry that employs thousands in San Antonio, but it brings us one step closer to curing infectious diseases and saving lives around the globe. I extend my most sincere congratulations to Dr. Anderson and thank him for his passion to improve lives," said Congressman Will Hurd, who represents the 23rd Congressional District of Texas, which includes San Antonio.

Research Background

Malaria, a protozoan parasite transmitted by mosquitoes, currently infects more than 200 million people worldwide, killing more than 400 thousand annually. While these numbers are still too high, enormous gains have been made, with numbers of malaria deaths dropping by 60% since 2000.

"Malaria control is currently riding a wave of success, largely on the back of a potent antimalarial called artemisinin, developed from a Chinese herbal remedy," explained Anderson. "This drug is used in a cocktail with one of several other antimalarials, and these combination therapies have been extraordinarily effective in reducing malaria deaths. There is now strong political will and a renewed push by donors such as the Bill and Melinda Gates Foundation to eliminate this disease. Unfortunately, the recent emergence of resistance to artemisinin now makes this a critical time for malaria control efforts."

Dr. Anderson's laboratory made two key discoveries concerning artemisinin resistance. Just three years after the emergence of artemisinin resistance was documented, his laboratory identified a small segment of the malaria parasite genome that contained the major resistance gene involved. The speed with which the genetic determinants of resistance were identified makes all the difference for malaria control efforts.

"Let me put this work in perspective." said Dr. Ian Cheeseman, Assistant Scientist at Texas Biomed, who worked with Anderson on this project. "Resistance to chloroquine, another antimalarial drug arose in the 1950s, but it was not until 2000 that the key gene involved was discovered. In the case of artemisinin, resistance was first demonstrated in 2009, just three years later we were able to map the approximate location of the gene involved, and another group finally determined the precise gene in 2014. The speed of this work buys us time to manage this problem."

Artemisinin resistance was first thought to be a problem only in Western Cambodia, and an aggressive campaign was put in place to contain and eliminate this focus of artemisinin resistant malaria. In 2012, Standwell Nkhoma, a researcher from Malawi working in Dr. Anderson's laboratory, demonstrated that artemisinin resistance had already spread far beyond the focus in Cambodia, and was rapidly spreading on the border of Thailand and Myanmar, 600 miles to the west.

"This work used more than 3,000 blood samples collected over 10 years by our collaborators in Thailand," explained Dr. Nkhoma. "We showed unambiguously that resistance was widespread in Southeast Asia and that a much more extensive campaign to contain resistance was needed."

Drug resistance has previously evolved to multiple other antimalarial drugs, including chloroquine and pyrimethamine, so resistance to artemisinin based drugs is no surprise.

"Artemisinin is used together with a partner drug to try to prevent evolution of resistance," Dr. Anderson said. "This clearly has not worked well - we need to follow the lead of HIV and TB researchers and start developing more complex drug combinations to stack the odds against malaria parasites. The problem is that we don't currently have available effective drugs to make such cocktails."

The Anderson laboratory previously surprised the malaria research community with their work on resistance to another antimalarial drug, pyrimethamine, demonstrating that resistance determinants have a single origin in Southeast Asia and then spread to Africa. "A major concern is that artemisinin resistance could spread from Southeast Asia to sub Saharan Africa, following the path of pyrimethamine resistance," explained Shalini Nair, a Senior Research Associate in Dr. Anderson's laboratory. "This would be disastrous for malaria control efforts"

Research Team and Funding

Dr. Anderson's malaria laboratory currently includes Shalini Nair, Marina McDew-White, Vinay Menon and Ann Arya, while he also runs a research program focusing on another widespread tropical parasitic disease, schistosomiasis. Dr. Anderson's malaria research would not be possible without close collaboration with François Nosten, M.D. of the Shoklo Malaria Research Unit, in Thailand, that is part of the Mahidol-Oxford Research Unit (MORU).

This MERIT Award is being issued from the NIH's National institute of Allergy and Infectious Diseases, grant number: 4R37AI048071-16.
Texas Biomed is one of the world's leading independent biomedical research institutions dedicated to advancing health worldwide through innovative biomedical research. Texas Biomed partners with hundreds of researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, herpes, hemorrhagic fevers and parasitic diseases responsible for malaria and schistosomiasis. The Institute also has programs in the genetics of cardiovascular disease, diabetes, obesity, psychiatric disorders and other diseases. For more information on Texas Biomed, go to

Texas Biomedical Research Institute

Related Evolution Articles:

Genome evolution goes digital
Dr. Alan Herbert from InsideOutBio describes ground-breaking research in a paper published online by Royal Society Open Science.
Paleontology: Experiments in evolution
A new find from Patagonia sheds light on the evolution of large predatory dinosaurs.
A window into evolution
The C4 cycle supercharges photosynthesis and evolved independently more than 62 times.
Is evolution predictable?
An international team of scientists working with Heliconius butterflies at the Smithsonian Tropical Research Institute (STRI) in Panama was faced with a mystery: how do pairs of unrelated butterflies from Peru to Costa Rica evolve nearly the same wing-color patterns over and over again?
Predicting evolution
A new method of 're-barcoding' DNA allows scientists to track rapid evolution in yeast.
Insect evolution: Insect evolution
Scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich have shown that the incidence of midge and fly larvae in amber is far higher than previously thought.
Evolution of aesthetic dentistry
One of the main goals of dental treatment is to mimic teeth and design smiles in the most natural and aesthetic manner, based on the individual and specific needs of the patient.
An evolution in the understanding of evolution
In an open-source research paper, a UVA Engineering professor and her former Ph.D. student share a new, more accurate method for modeling evolutionary change.
Chemical evolution -- One-pot wonder
Before life, there was RNA: Scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich show how the four different letters of this genetic alphabet could be created from simple precursor molecules on early Earth -- under the same environmental conditions.
Catching evolution in the act
Researchers have produced some of the first evidence that shows that artificial selection and natural selection act on the same genes, a hypothesis predicted by Charles Darwin in 1859.
More Evolution News and Evolution Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#566 Is Your Gut Leaking?
This week we're busting the human gut wide open with Dr. Alessio Fasano from the Center for Celiac Research and Treatment at Massachusetts General Hospital. Join host Anika Hazra for our discussion separating fact from fiction on the controversial topic of leaky gut syndrome. We cover everything from what causes a leaky gut to interpreting the results of a gut microbiome test! Related links: Center for Celiac Research and Treatment website and their YouTube channel
Now Playing: Radiolab

The Flag and the Fury
How do you actually make change in the world? For 126 years, Mississippi has had the Confederate battle flag on their state flag, and they were the last state in the nation where that emblem remained "officially" flying.  A few days ago, that flag came down. A few days before that, it coming down would have seemed impossible. We dive into the story behind this de-flagging: a journey involving a clash of histories, designs, families, and even cheerleading. This show is a collaboration with OSM Audio. Kiese Laymon's memoir Heavy is here. And the Hospitality Flag webpage is here.